聚合内容 The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
更新时间: 16 分钟 35 秒 前

Akashi Therapeutics Receives Collective Funding of $1.5 Million to Support HT-100 Clinical Development

周四, 07/03/2014 - 12:55
CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Akashi Therapeutics, Inc. announced today that the Muscular Dystrophy Association (MDA) has made an investment through the MDA Venture Philanthropy program to help fund clinical development of HT-10...
Biopharmaceuticals, Venture Capital
Akashi Therapeutics, HT-100, halofuginone, Duchenne muscular dystrophy

Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack(R) model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales

周三, 07/02/2014 - 15:56
ASHKELON, Israel, July 2, 2014 -- (Healthcare Sales & Marketing Network) -- Integrity Applications, Inc. (IGAP) (the "Company" or "Integrity"), developer of the GlucoTrack model DF-F noninvasive blood glucose measurement device, announ...
Devices, Monitoring, Endocrinology, Personnel
Integrity Applications, GlucoTrack

Alnylam Elects Amy Schulman to its Board of Directors

周三, 07/02/2014 - 15:51
Appointment of Industry Leader Brings Broad Strategic, Commercial, and Legal Experience to Board CAMBRIDGE, Mass.--(Healthcare Sales & Marketing Network)--Alnylam Pharmaceuticals, Inc. (ALNY), a leading RNAi therapeutics company, announced today the ele...
Biopharmaceuticals, Personnel
Alnylam Pharmaceuticals, RNAi therapeutics, patisiran

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy

周三, 07/02/2014 - 15:35
PHOENIX, AZ--(Healthcare Sales & Marketing Network) - Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food an...
Biopharmaceuticals, Neurology, FDA
Insys Therapeutics, cannabidiol, Dravet syndrome, epilepsy

Genentech Announces Definitive Agreement to Acquire Seragon Pharmaceuticals

周三, 07/02/2014 - 15:31
Acquisition of Phase I program offers a potential new approach for hormone receptor-positive breast cancer SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today an...
Biopharmaceuticals, Oncology, Mergers & Acquisitions
Genentech, Seragon Pharmaceuticals, selective estrogen receptor, breast cancer

Intuitive Surgical to Begin Direct Sales of da Vinci(R) Surgical Systems in Japan

周三, 07/02/2014 - 15:28
SUNNYVALE, Calif., July 1, 2014 -- (Healthcare Sales & Marketing Network) -- Intuitive Surgical (ISRG) and Adachi Co. Ltd. today announced an agreement to transition Japanese sales, marketing, service, support and training for da Vinci(R) Systems, instrume...
Devices, Surgery, Distribution
Intuitive Surgical, da Vinci, robotic surgery

Alere Announces Management Transition

周二, 07/01/2014 - 13:49
Ron Zwanziger Resigns as Chief Executive Officer and President; Namal Nawana Appointed Interim CEO WALTHAM, Mass., July 1, 2014 -- (Healthcare Sales & Marketing Network) -- Alere Inc. (ALR), a global leader in empowering individuals to take greater con...
Devices, Monitoring, Personnel
Alere Inc

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong